EarningsQ3 2024 Earnings Report

Tandem Diabetes Care (TNDM) Q3 2024 Earnings Report

0 Followers

MX:TNDM Q3 2024 EPS Results

Actual EPS-$6.44

Consensus EPS-$7.42

Beat/MissBeat by +$0.98

One Year Ago EPS-$9.39

Actual Revenue$4.49B

Expected Revenue$4.13B

Beat/MissBeat by +$365.23M

YoY Revenue Growth+31.43%

QuarterQ3 2024

Date11/06/2024

TimeAfter Close

Conference CallWednesday, November 6, 2024

MX:TNDM Upcoming Earnings

Tandem Diabetes Care's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

MX:TNDM Q3 2024 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q3)	-4.51 / -	-5.764	―
Aug 06, 2026	2026 (Q2)	-5.91 / -5.65	-8.876	36.31% (+3.22)
May 07, 2026	2026 (Q1)	-8.18 / -5.49	-12.319	55.46% (+6.83)
Feb 19, 2026	2025 (Q4)	-1.71 / -0.17	0.184	-190.00% (-0.35)
Nov 06, 2025	2025 (Q3)	-6.06 / -5.76	-6.445	10.57% (+0.68)
Aug 06, 2025	2025 (Q2)	-7.35 / -8.88	-8.655	-2.55% (-0.22)
Apr 30, 2025	2025 (Q1)	-11.14 / -12.32	-11.969	-2.92% (-0.35)
Feb 26, 2025	2024 (Q4)	-3.76 / 0.18	-8.471	102.17% (+8.65)
Nov 06, 2024	2024 (Q3)	-7.42 / -6.44	-9.391	31.37% (+2.95)
Aug 01, 2024	2024 (Q2)	-9.85 / -8.65	-10.128	14.55% (+1.47)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed